Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Heparin personal injury suit

This article was originally published in The Tan Sheet

Executive Summary

A personal injury lawsuit was filed against Camden, N.J.-based Baxter Healthcare in federal court in New Jersey, according to New York-based law firm Lieff Cabraser Heimann & Bernstein. The plaintiff in the law suit claims to have suffered a near fatal adverse reaction from Baxter's contaminated heparin prescription blood thinner. The complaint seeks damages for physical pain and medical expenses, along with punitive damages to prevent Baxter from "similar wrongdoing in the future," according to the firm's April 3 release. Baxter came under fire after its failure to inspect a Chinese manufacturer that was the source of an ingredient used in heparin products that may be connected with hundreds of adverse events and four deaths (1"The Tan Sheet" Feb. 25, 2008, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel